BXP vs ERNA · rev $3.48B vs P/E 0.0, rev $582.0K
Boston Properties Inc (BXP) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
BXP currently screens at market cap $12.12B. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the BXP and ERNA stock pages for the full models.
Not investment advice.